Sign in to view content

Clinical Effects of Blocking Ang-2 and VEGF with Faricimab in the Phase 2 STAIRWAY Trial

Carl J Danzig, MD

Video
Published 2020

Related

Elamipretide, a Mitochondrial-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with High Risk Drusen
Michael J Allingham, MD, PhD
Annual Meeting Talks
2019
Evaluation of 8 mg Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration: Results from the Phase 2 CANDELA Study
W. Lloyd Clark, MD, FASRS
Updates from the Field
2022
Race Representation in Diabetic Macular Edema Randomized Control Trials Compared to the United States Census Data
Abdul-Hadi Kaakour, MD, MS
Annual Meeting Talks
2021

Category: AMD-Neovascular

See more